IRIS Accounts Production v23.4.0.336 03259980 Board of Directors 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032599802022-06-30032599802023-06-30032599802022-07-012023-06-30032599802021-06-30032599802021-07-012022-06-30032599802022-06-3003259980ns15:EnglandWales2022-07-012023-06-3003259980ns14:PoundSterling2022-07-012023-06-3003259980ns10:Director12022-07-012023-06-3003259980ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3003259980ns10:SmallEntities2022-07-012023-06-3003259980ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3003259980ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3003259980ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3003259980ns10:AbridgedAccounts2022-07-012023-06-3003259980ns10:OrdinaryShareClass12022-07-012023-06-3003259980ns10:Director22022-07-012023-06-3003259980ns10:Director32022-07-012023-06-3003259980ns10:Director42022-07-012023-06-3003259980ns10:Director52022-07-012023-06-3003259980ns10:RegisteredOffice2022-07-012023-06-3003259980ns5:CurrentFinancialInstruments2023-06-3003259980ns5:CurrentFinancialInstruments2022-06-3003259980ns5:Non-currentFinancialInstruments2023-06-3003259980ns5:Non-currentFinancialInstruments2022-06-3003259980ns5:ShareCapital2023-06-3003259980ns5:ShareCapital2022-06-3003259980ns5:RetainedEarningsAccumulatedLosses2023-06-3003259980ns5:RetainedEarningsAccumulatedLosses2022-06-3003259980ns5:FurnitureFittings2022-07-012023-06-3003259980ns5:MotorVehicles2022-07-012023-06-3003259980ns10:OrdinaryShareClass12023-06-30
REGISTERED NUMBER: 03259980 (England and Wales)















Financial Statements for the Year Ended 30 June 2023

for

Villapharm Limited

Villapharm Limited (Registered number: 03259980)






Contents of the Financial Statements
for the Year Ended 30 June 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Villapharm Limited

Company Information
for the Year Ended 30 June 2023







DIRECTORS: Dr V Okpiabhele
Dr C Tetteh
Mr S Dafiaga
Mr O A Majekodunmi
Mr F T Balogun





REGISTERED OFFICE: 36 The Street
Capel St. Mary
Ipswich
IP9 2EE





REGISTERED NUMBER: 03259980 (England and Wales)





ACCOUNTANTS: Nielsens
Chartered Accountants
The Gatehouse
453 Cranbrook Road
Ilford
Essex
IG2 6EW

Villapharm Limited (Registered number: 03259980)

Abridged Balance Sheet
30 June 2023

30.6.23 30.6.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,787 3,284

CURRENT ASSETS
Stocks 95,000 74,500
Debtors 425,154 366,709
Cash at bank and in hand 27,716 69,515
547,870 510,724
CREDITORS
Amounts falling due within one year 338,583 319,018
NET CURRENT ASSETS 209,287 191,706
TOTAL ASSETS LESS CURRENT
LIABILITIES

211,074

194,990

CREDITORS
Amounts falling due after more than one year 18,518 28,518
NET ASSETS 192,556 166,472

CAPITAL AND RESERVES
Called up share capital 5 4 4
Retained earnings 192,552 166,468
SHAREHOLDERS' FUNDS 192,556 166,472

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Villapharm Limited (Registered number: 03259980)

Abridged Balance Sheet - continued
30 June 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 30 June 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 March 2024 and were signed on its behalf by:





Mr F T Balogun - Director


Villapharm Limited (Registered number: 03259980)

Notes to the Financial Statements
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

Villapharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings & equipment - 25% on cost
Motor vehicles - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Villapharm Limited (Registered number: 03259980)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2022 - 6 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 July 2022
and 30 June 2023 42,068
DEPRECIATION
At 1 July 2022 38,784
Charge for year 1,497
At 30 June 2023 40,281
NET BOOK VALUE
At 30 June 2023 1,787
At 30 June 2022 3,284

5. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 30.6.23 30.6.22
value: £    £   
4 Share capital £1.00 4 4